Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Electra Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Electra Therapeutics

Electra Therapeutics

Biotech firm innovating SIRP-targeted antibody therapies for cancer and immunological diseases.

HQ
San Francisco, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to pioneer breakthrough therapies for cancer and immunological diseases, Electra Therapeutics focuses on developing innovative SIRP-targeted antibody treatments. Their core vision is to explore and validate novel targets rigorously, aiming to address critical unmet needs in the medical field. The company's unique portfolio of Signal Regulatory Proteins (SIRP)-directed antibodies operates through a distinct mechanism of action, potentially addressing the underlying pathology across a broad spectrum of diseases.

Electra Therapeutics has garnered attention from notable investors and industry leaders due to its cutting-edge approach and promising therapeutic pipeline. The company has achieved significant milestones in preclinical and clinical development, positioning itself as a key player in the biotechnology sector. By advancing the understanding and application of SIRP-targeted therapies, Electra Therapeutics is making a substantial impact on the treatment landscape for cancer and immunological diseases.

Electra Therapeutics - Similar Companies

EpiBiologics logo

EpiBiologics

epibiologics.com

AltruBio logo

AltruBio

Star Therapeutics logo

Star Therapeutics

Ernexa Therapeutics logo

Ernexa Therapeutics

eternatx.com

Ingenia Therapeutics logo

Ingenia Therapeutics

ingeniatx.com

argenx logo

argenx

EtiraRx logo

EtiraRx

etirarx.com

Elevar Therapeutics logo

Elevar Therapeutics

LTZ Therapeutics logo

LTZ Therapeutics

Dren Bio logo

Dren Bio

drenbio.com

SunnyBay BioTech logo

SunnyBay BioTech

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

Soteria Biotherapeutics logo

Soteria Biotherapeutics

Eureka Therapeutics logo

Eureka Therapeutics

eurekainc.com

ImmuneID logo

ImmuneID

Electra Therapeutics - Quick Facts

Who are Electra Therapeutics' competitors?

Companies similar to Electra Therapeutics include EpiBiologics, AltruBio, Star Therapeutics and Ernexa Therapeutics.

When was Electra Therapeutics founded?

Electra Therapeutics was founded in 2018.

Where is Electra Therapeutics' headquarters located?

Electra Therapeutics' headquarters is located in San Francisco, CA, US.

When was Electra Therapeutics' last funding round?

Electra Therapeutics' most recent funding round was for $84M (USD) in February 2022.

How much has Electra Therapeutics raised to-date?

As of Feb 16, 2022, Electra Therapeutics has raised a total of $100M (USD).

How many employees does Electra Therapeutics have?

Electra Therapeutics has 30 employees as of Feb 4, 2024.

Electra Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibody Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified